Docetaxel given after doxorubicin reduces recurrence

[News]

Adding the drug docetaxel to anthracycline-based chemotherapy slightly improved disease-free survival in breast cancer patients, according to a randomized clinical trial published online January 8 in the Journal of the National Cancer Institute.

More... (http://www.news-medical.net/?id=34113)